SPOTLIGHT -
US Secures Johnson & Johnson Coronavirus Vaccine Deal
BARDA is committing over $1 billion for the agreement, which is dependent on approval or emergency use authorization by the US FDA.
Read More
NIH Antibody Trials for COVID-19 Move Forward
Two studies will investigate monoclonal antibody-based treatments in both patients with mild disease and those who are hospitalized.
Dr. Pat Soon-Shiong: Cytokine or Cytopathic Storm?
Dr. Patrick Soon-Shiong, CEO of ImmunityBio, initiates a conversation on the nature of the SARS-CoV-2 cytokine storm.
Comparing SARS-CoV-1 & -2
Adam Brufsky, MD, explains the insights years of research into SARS-CoV-1 may hold for SARS-CoV-2.
FDA, Advocacy Group Clash Over Hydroxychloroquine
As the debate on hydroxychloroquine rages on, the FDA and a new advocacy group have sparred about the appropriateness of physicians prescribing the drug for COVID-19.
Lilly, NIAID Launch Phase 3 Prevention Trial Centered on Nursing Homes
The trial will assess a monoclonal antibody based investigational treatment that may prevent COVID-19.
Technique Predicts Stability of Potential Monoclonal Antibody Therapies
Collodial stability measures may predict whether a potential antibody-based treatment will work early on in the drug development process.
Fauci Testifies on Unifying Coronavirus Response at Hearing
Dr. Anthony Fauci, CDC's Dr. Robert Redfield, & HHS' Admiral Brett Giroir spoke at a congressional hearing on coordinating the future of the national coronavirus response.
Dr. Peter Hotez Argues for Federal Coordination of COVID-19 Response
Peter Hotez, MD, PhD, recently authored a paper proposing a federally directed but state-adaptive reopening that aims for acceptable national suppression by October 1.
Dual Anti-Viral/Anti-Inflammatory Drug Study Against COVID-19 Begins
RedHill Biopharma has initiated a global phase 2/3 study in order to evaluate the use of opaganib in patients with severe COVID-19.
Herman Cain Passes After 3-Week Coronavirus Battle
On Tuesday, Cain was said to be recovering, possibly reflecting the complex immune system stages of COVID-19 disease course.
Early COVID-19 Cases Linked to China, Italy, Iran
People with travel links to China, Iran, and Italy may have accounted for nearly two-thirds of early COVID-19 cases in affected countries.
Quest: FDA Authorization Could Raise Daily Test Capacity by 35000
The method extracts SARS-CoV-2 RNA with the Mag-Bind Viral RNA Xpress Kit and the Hamilton MagEx STAR.
Connecting COVID-19 to Cancer Research
Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.
Ebola Survivors Face Stigma, Reproductive Health Impact
Infectious disease specialists explain how long term international cooperation with impacted societies can help to stop the cycle of Ebola outbreaks.
Can We Fight Coronavirus Without a Vaccine? Explaining Monoclonal Antibody Research
What happens if we don't get a COVID-19 vaccine? Patrick Soon-Shiong, MD, describes another potential route for research efforts, which could also supplement vaccine development.
Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Can Moderna's COVID 19 Vaccine Generate Lasting Immunity?
Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.
Small Quantity of Sedative Dexmedetomidine Recalled Due to Cross-Contamination
Weekly, we identify FDA product and drug recalls which have the potential to be clinically relevant.
Strokes Linked to COVID-19 Appear More Dangerous
Stroke associated with SARS-CoV-2 infection appears to be more dangerous for patients relative to the baseline risk from stroke, according to a study published earlier this month.
New CDC Guidelines Highlight School Reopenings in Europe, Asia
There is mixed international evidence about whether returning to school results in increased transmission or outbreaks, authors explained, and surges may be multiply determined.
Effective Decontamination Methods Critical to Preserving N95 Mask Integrity
Some ways of decontaminating N-95 respirator masks can degrade mask integrity, according to the authors of a recent study.
Benefits of Routine Childhood Vaccination Versus Risk of Coronavirus Infection
A benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
A World Without Antibiotics? Why Patients Should Care About Resistance
Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.
The Stakes of Antibiotic Stewardship
Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
FDA Approves OraRisk Coronavirus PCR Test
The test is not FDA approved, but is instead authorized for emergency use in the context of the SARS-CoV-2 pandemic.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
Adenovirus Vector Vaccine Shows Promise Against SARS-CoV-2
A single injection of the Ad5-vectored COVID-19 vaccine induced specific immune responses to the spike glycoprotein at day 28.